Our group recently reported a significant correlation between advanced clinicopathologic parameters and lower plasma IGF-1 levels in patients with HCC, IGF-1 has emerged as a substitute biomarker for Liver reserve and we have showed the usefulness of adding it to the CTP score; substituting ascites and encephalopathy [19]. The gene discussed is IGF1; the disease is Ascites.